Wells Fargo & Company Boosts COPT Defense Properties (NYSE:CDP) Price Target to $36.00

COPT Defense Properties (NYSE:CDPGet Free Report) had its price target lifted by investment analysts at Wells Fargo & Company from $35.00 to $36.00 in a report released on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 13.44% from the stock’s previous close.

Several other brokerages also recently weighed in on CDP. Evercore reaffirmed an “outperform” rating and set a $38.00 target price on shares of COPT Defense Properties in a research note on Tuesday, April 28th. Truist Financial increased their price target on COPT Defense Properties from $31.00 to $33.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. JPMorgan Chase & Co. raised their price target on COPT Defense Properties from $33.00 to $34.00 and gave the company a “neutral” rating in a report on Friday, May 15th. Weiss Ratings upgraded shares of COPT Defense Properties from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, April 21st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $37.00 price objective on shares of COPT Defense Properties in a report on Wednesday, April 29th. Five investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $34.88.

Check Out Our Latest Stock Analysis on CDP

COPT Defense Properties Stock Performance

NYSE CDP traded down $0.33 on Monday, hitting $31.74. The stock had a trading volume of 145,396 shares, compared to its average volume of 1,102,372. The company’s 50-day moving average is $31.74 and its two-hundred day moving average is $30.82. COPT Defense Properties has a one year low of $26.91 and a one year high of $33.33. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of 22.99 and a beta of 0.79. The company has a quick ratio of 2.85, a current ratio of 2.85 and a debt-to-equity ratio of 1.63.

COPT Defense Properties (NYSE:CDPGet Free Report) last released its quarterly earnings results on Monday, April 27th. The company reported $0.34 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.34). The business had revenue of $200.64 million for the quarter, compared to the consensus estimate of $185.10 million. COPT Defense Properties had a net margin of 20.10% and a return on equity of 10.02%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the firm posted $0.65 EPS. COPT Defense Properties has set its FY 2026 guidance at 2.730-2.790 EPS and its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts expect that COPT Defense Properties will post 2.78 earnings per share for the current year.

Insider Buying and Selling at COPT Defense Properties

In related news, Director Robert L. Denton sold 3,922 shares of the firm’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $32.38, for a total transaction of $126,994.36. Following the completion of the transaction, the director owned 3,803 shares of the company’s stock, valued at $123,141.14. This trade represents a 50.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 1.66% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On COPT Defense Properties

Several hedge funds and other institutional investors have recently bought and sold shares of the business. UBS Group AG raised its holdings in shares of COPT Defense Properties by 229.6% in the 4th quarter. UBS Group AG now owns 457,210 shares of the company’s stock worth $12,710,000 after purchasing an additional 318,493 shares in the last quarter. Easterly Investment Partners LLC boosted its holdings in COPT Defense Properties by 154.2% during the fourth quarter. Easterly Investment Partners LLC now owns 299,934 shares of the company’s stock worth $8,338,000 after buying an additional 181,935 shares in the last quarter. Picton Mahoney Asset Management grew its position in COPT Defense Properties by 83,723.7% in the third quarter. Picton Mahoney Asset Management now owns 31,853 shares of the company’s stock worth $924,000 after buying an additional 31,815 shares during the last quarter. Allianz Asset Management GmbH grew its position in COPT Defense Properties by 31.9% in the third quarter. Allianz Asset Management GmbH now owns 461,797 shares of the company’s stock worth $13,420,000 after buying an additional 111,696 shares during the last quarter. Finally, Channing Capital Management LLC increased its holdings in shares of COPT Defense Properties by 21.0% in the third quarter. Channing Capital Management LLC now owns 2,913,596 shares of the company’s stock valued at $84,669,000 after buying an additional 506,593 shares in the last quarter.

About COPT Defense Properties

(Get Free Report)

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.

Featured Stories

Analyst Recommendations for COPT Defense Properties (NYSE:CDP)

Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.